Pacific ASC will be built at the Shops at Dole Cannery. Cellular Bioengineering is developing a line of artificial corneas that the company hopes to have government clearance for implanting by the end of next year, according to the report.
Officials from Cellular Bioengineering did not release any further details about Pacific ASC.
Read the Business Journal’s report about Pacific ASC.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
